Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHCT
Community Healthcare Trust
CHCT
|
+$7.01M |
| 2 |
Nasdaq
NDAQ
|
+$3.81M |
| 3 |
Monro
MNRO
|
+$3.66M |
| 4 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$3.21M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$3.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merit Medical Systems
MMSI
|
+$3.78M |
| 2 |
Novanta
NOVT
|
+$3.31M |
| 3 |
Rogers Corp
ROG
|
+$2.42M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$2.17M |
| 5 |
DGI
DigitalGlobe Inc.
DGI
|
+$2.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.69% |
| 2 | Technology | 16.96% |
| 3 | Financials | 14.78% |
| 4 | Healthcare | 12.79% |
| 5 | Consumer Discretionary | 7.27% |
Similar funds
Aristotle Capital Boston's Q3 2017 Portfolio in Review
As of Q3 2017, Aristotle Capital Boston held 125 positions worth $1.12B, up 25% from $896M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Aristotle Capital Boston deployed $151M of net new capital in Q3 2017, opening 2 new positions and adding to 90 existing holdings. Its largest new stake was Community Healthcare Trust: 271,951 shares worth $7.33M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Merit Medical Systems, an estimated $3.78M trimmed.
- Aristotle Capital Boston's largest Q3 2017 buy was Community Healthcare Trust: 271,951 shares worth $7.33M.
- Aristotle Capital Boston added most to Nasdaq in Q3 2017, an estimated $3.81M increase.
- Aristotle Capital Boston's biggest Q3 2017 reduction was Merit Medical Systems, cutting an estimated $3.78M.
- Aristotle Capital Boston fully exited Neustar Inc in Q3 2017, selling an estimated $956K.
- Aristotle Capital Boston's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2017.
- Aristotle Capital Boston opened 2 new positions and closed 1 in Q3 2017.
- Aristotle Capital Boston's portfolio value rose 25% quarter-over-quarter to $1.12B.
Based on Aristotle Capital Boston's 13F filing for Q3 2017, filed 14 Nov 2017.